Medicare Issues Final Local Coverage Decision For Bio-Techne`s ExoDxTM Prostate(IntelliScore) Test
(World News USA)

MINNEAPOLIS, Oct. 10, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that the Medicare Administrative Contractor (MAC) National Government Services, Inc. issued a final Local Coverage Decision (LCD) covering the ExoDx Prostate(IntelliScore) - EPI - test for men who are being considered for an initial prostate biopsy. The decision is effective for tests administered on or after December 1,...